Современные принципы консервативного лечения недержания мочи у женщин


Цитировать

Полный текст

Аннотация

Об авторах

И А Аполихина

ГУ Научный центр акушерства, гинекологии и перинатологии РАМН

Москва; ГУ Научный центр акушерства, гинекологии и перинатологии РАМН

В В Ромих

НИИ урологии МЗ и СР РФ

Москва; НИИ урологии МЗ и СР РФ

В М Андикян

ГУ Научный центр акушерства, гинекологии и перинатологии РАМН

Москва; ГУ Научный центр акушерства, гинекологии и перинатологии РАМН

Список литературы

  1. Janssen С. С., Lagro-Janssen A. L., Felling A. J. The effects of physiotherapy for female urinary incontinence: individual compared with group treatment. Br. J. Urol. Int. 2001; 87(3): 201- 206.
  2. McDowell B. J., Engberg S., Serelka S. et al. Effectiveness of behavioral therapy to treat incontinence in homebound older adults. J. Am. Geriatr. Soc. 1999; 47(3): 309-318.
  3. Gupta S. K., Sathyan G. Pharmacokinetics of an oral once-aday controlled release oxybutynin formalation compared with immediate-release oxvbutynin. J. Clin. Pharmacol. 1999; 39(3): 289-296.
  4. Anderson R. U., Mobley D., Blank B. et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J. Urol. (Baltimore) 1999; 161(6): 1809-1812.
  5. Haferkamp A., Staehler G., Gerner H. J., Dorsam J. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord. 2000; 38(4): 250-254.
  6. Wang C. Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin. Yi Xue Za Zhi 2000; 23(10): 590-599.
  7. Nilsson С. G., Lukkari E. Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients. Neurourol. and Urodyn. 1997; 16(6): 533-542.
  8. Appell R. A. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997; 50(6A, suppl): 90-96. Discus.: 97-99.
  9. Appell R. A., Sand P., Dmochowski R. et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bledder: results of the OBJECT Study. Mayo Clin. Proc. 2001; 76(4): 353-355.
  10. Gleason D. M., Susset J., White C. et al. Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL. Study Group. Urology 1999; 54(3): 420-423.
  11. Millard R., Turtle J., Moore K. et ak. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity [see comments]. J. Urol. (Baltimore) 1999; 161(5): 1551-1555. (Comment. - 1556).
  12. Yono M., Yoshida M., Takahashi W. et al. Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle. Br. J. Urol. Int. 2000; 86(6): 719-725.
  13. Malone-Lee J., Shaffu В., Anand C., Powell С. Tolterodine: superior toleability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial. J. Urol. (Baltimore) 2001; 165(5): 1452-1456.
  14. Лопаткин Н. А., Телешова С. С. Троспиум хлорид 40 мг (Спазмекс) - плацебо-контролируемое рандомизированное двойное слепое трехнедельное клиническое исследование эффективности и переносимости пациентов со сложной формой недержания мочи при напряжении в сочетании с моторным неудержанием. В кн.: Пленум Правления Российского о-ва урологов: Материалы. М.; 2001. 113-114.
  15. Petros P. P., Skilling P. M. Pelvic floor rehabilitation in the female according to the integral theory of female urinary incontinence. First report. Eur. J. Obstet Gvnecol. Reprod. Biol. 2001; 94(2): 264-269.
  16. Rechberger Т., Miturski R. Immunohistochemical localization of estrogen receptors in vesicovaginal fascia among female patients with stress incontinence - preliminary report. Ginekol. Pol. 1995; 66(4): 231-236.
  17. Flamant G., Gillet J. Y. Prise en charge medicamenteuse de l'lincontinence urinaire feminine. Presse Med. 1995; 24(1): 31-34.
  18. Kuchel G. A., Tannenbaum C., Greenspan S. L., Resnick N. M. Can variability in the hormonal status of elderle women assist in the decision to administer estrogens? J. Womens Hlth Gend. Based Med. 2001; 10(2): 109-116.
  19. Samsioe G. Urogenital aging-a hidden problem. Am. J. Obstet Gynecol. 1998; 178(5): S245-S249.
  20. Tsai E., Yang C., Chen H. et al. Bladder neck circulation by Doopler uktrasonography in postmenopausal women with urinary stress incontinence. Obstet and Gynecol. 2001; 98(1): 52-56.
  21. Ouslander J. G., Greendale G. A., Uman G. et al. Effects of oral oestrogen and progestin on the lower urinary tract among female nursing home residents. J. Am. Geriatr. Soc. 2001; 49(6): 803-807.
  22. Stenberg A., Heimer G., Holmberg L., Ulmsten U. Prevalence of postmenopausal symptoms in two age groups of elderly women in relation to oestrogen replacement therapy. Maturitas 1999; 33(3): 229-237.
  23. Pelvic floor muscle training for urinary incontinence in women. (Cochrane review) / Hay-Smith E., Bo K., Berghmans L. et al. Oxford: The Cochrane Library; 2001.
  24. Abrams P., Cardozo L., Khoury S., Wein A. Incontinence. In: Second International consultation on incontinence. 2nd ed. 2002. 573-624.
  25. Kegel A. H. Progressive resistance exercise in the functional restoration of the perineal muscles. Am. J. Obstet Gynecol. 1948; 56: 238-249.
  26. Devillers P., Mauroy B. Reeducation uro-gynecologique feminine. Techniques et indications. Progr. Urol. 1997; 7(4): 683- 693.
  27. Morkved S., Bo K., Fjortoft T. Is there ane additional effect off adding biofeedback to pelciv floor muscle training? A singleblind randomized controlled trial. Obstet and Gvnecol. 2002; 100(4): 730-739.
  28. Gunnarsson M., Ahlmann S., Lindstrom S. et al. Cortical magnetic stimulation in patients with genuine stress incontinence: correlation with results of pelvic floor exercises. Neurol, and Urodyn. 1999; 18(5): 437-444. Discus.: 444-445.
  29. Palermo P., Carta G., Spacca G. et al. Pelvic floor rehabilitation in woomen affected with stress urinary incontinence. Author's experince. Minerva Ginecol. 1998; 50(11): 455-458.
  30. Шатров Ф. 3., Хамидуллин Р. Ф., Ихсанов И. Н. и др. Лечебная физкультура в комплексном лечении женщин, страдающих недержанием мочи. В кн.: Пленум Правления Российского о-ва урологов: Материалы. М.; 2001. 172-173.
  31. Cammu Н., Van-Nylen M. Pelvic floor muscle exercises: 5 vears later. Urology 1995; 45(1): 113-117. Discus.: 118.
  32. Bump R., Hurt W. G., Fantl J. A., Wyman J. F. Assessment of Kegel exercise performance after brief verbal instruction. Am. J. Obstet Gynecol. 1991; 165(2): 322-329.
  33. Herbison P., Plevnik S., Mantle J. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst. Rev. 2000: 2: CD002114.
  34. Delias A., Drewe J. Conservative therapy of female genuine stress incontinence with vaginal cones. Eur. J. Obstet Gynecol. Reprod. Biol. 1995; 62(2): 213-215.
  35. Peschers U., Zen-Ruffinen F., Schaer G. N., Schussler B. Der VIVA- Urethrastopsel: Eine sinnvolle Erweiterung des Spektrums zur konservativen Therapie der Stressharninkontinenz? Geburtsh. u. Frauenheilk. 1996; 56(3): 118-123.
  36. Pages I. H., Jahr S., Schaufele M. K., Conradl E. Comparative analysis of biofeedback and physical therapy for treatment of urinary stress incontinence in women. Am. J. Phys. Med. Rehabil. 2001; 80(7): 494-502.
  37. Wilson P. D., Samarrai T. A. L., Deakin M. et al. An objective assessment of physiotherapy for female genuine stress incontinence. Br. J. Obstetr. Gynaecol. 1987; 94: 575-582.
  38. Vecchioli-Scaldazza С. Rehabilitative treatment of non-neurogenic female urinary incontinence. Clinical and urodynamic evaluation. Minerva Urol. Nefrol. 1997; 49(1): 5-8.
  39. Bourcier A. P., Juras J. С. Nonsurgical therapy for stress incontinence. Urol. Clin. N. Am. 1995; 22(3): 613-627.
  40. Susset J., Gales G., Manbeck K., Susset A. A predictive score index for the outcome of associated biofeedback and vaginal electrical stimulation in the treatment of female incontinence. J. Urol. (Baltimore) 1995; 153(5): 1461-1466.
  41. Sung M. S., Hong J. Y., Choi Y. H. et al. FES-biofeedback versus intensive pelvic floor muscle exercise for the prevention and treatment of genuine stress incontinence. J. Korean Med. Sci. 2000; 15(3): 303-308.
  42. Moore К. Н. Conservative management for urinary incontinence. Baillieres Best. Pract. Res. Clin. Obstet Gynaecol. 2000; 14(2): 251-289.
  43. Weinberger M. W., Goodman В. М., Carnes M. Long-term efficacy of nonsurgical urinary incontinence treatment in elderly women. J. Gerontol. A. Biol. Sci. Med. Sci. 1999; 54(3): M117-M121.
  44. Hirsch A., Weirauch G., Steimer B. et al. Treatment of female urinary incontinence with EMG-controlled biofeedback home training. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19991; 10(1): 7-10.
  45. Estenban-Fuertes M., Salinas-Casado J., Angulo-Cuesta J. et al. Occlusive urethral systems: can they constitute an alternative in the management of female stress incontinence? Arch. Esp. Urol. 1998; 51(1): 71-77.
  46. Пушкарь Д. Ю. Возможности улучшения качества жизни больных недержанием мочи с помощью использования уретральных клапанов-обтураторов. В кн.: Пленум Правления Российского о-ва урологов: Материалы. М.: 2001. 140-141.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2005